Two personal perspectives on a key issue in contemporary 3D QSAR

Wiley Interdisciplinary Reviews: Computational Molecular Science

Volumn 2, Issue 1, 2012, Pages 108-113

  Clark, Robert D ^a,c   Norinder, Ulf ^b  

^a AstraZeneca Research and Development ^*

^b ASTRAZENECA R AND D   (Sweden)

^c Simulations Plus Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84857770727     PISSN: 17590876     EISSN: 17590884     Source Type: Journal    
DOI: 10.1002/wcms.69     Document Type: Article

References (23)

1. Netzeva TI, Worth AP, Aldenberg T, Benigni R, Cronin MTD, Gramatica P, Jaworska JS, Kahn S, Klopman G, Marchant CA, et al. Current status of methods for defining the applicability domain of (quantitative) structure-activity relationships. The report and recommendations of ECVAM workshop 521. ATLA 2005, 33:155-173.
2. Tetko IV, Bruneau P, Mewes H-W, Rohrer DC, Poda GI. Can we estimate the accuracy of ADME-Tox predictions? Drug Disco Today 2006, 11:700-707.
3. Warren GL, Andrews CW, Capelli A-M, Clarke B, LaLonde J, Lambert MH, Lindvall M, Nevins N, Semus SF, Senger S, et al. A critical assessment of docking programs and scoring functions. J Med Chem 2006, 49:5912-5931.
4. Enyedy IJ, Egan WJ. Can we use docking and scoring for hit-to-lead optimization? J Comput Aided Mol Des 2008, 22:161-168.
5. Cramer RD III, Patterson DE, Bunce JD. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 1988, 110:5959-5967.
6. Klebe G, Abraham U, Mietzner T. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J Med Chem 1994, 37:4130-4146
7. Watson KA, Mitchell EP, Johnson LN, Cruciani G, Son JC, Bichard CJF, Fleet GWJ, Oikonomakos NG, Kontou M, Zographos SE. Glucose analogue inhibitors of glycogen phosphorylase: from crystallographic analysis to drug prediction using GRID force field and GOLPE variable selection. Acta Cryst 1995, D51:458-472.
8. Cho SJ, Tropsha A. Cross-validated R2-guided region selection for comparative molecular field analysis: a simple method to achieve consistent results. J Med Chem 1995, 1060-1066.
9. Norinder U. Single and domain mode variable selection in 3D QSAR applications. J Chemometrics 1996, 10:95-105.
10. Wang R, Gao Y, Liu L, Lai L. All-orientation search and all-placement search in comparative molecular field analysis. J Mol Model 1998, 4:276-283.
11. Prasanna S, Daga PR, Xie A, Doerksen RJ. Glycogen synthase kinase-3 inhibition by 3-anilino-4-phenylmaleimides: insights from 3D-QSAR and docking. J Comput Aided Mol Des 2009, 23:113-127.
12. Murugesan V, Prabhakar YS, Katti SB. CoMFA and CoMSIA studies on thiazolidin-4-one as anti-HIV-1 agents. J Mol Graph Model 2009, 27:735-743.
13. Patel PD, Patel MR, Kaushik-Basu N, Talele TT. 3D QSAR and molecular docking studies of benzimidazole derivatives as hepatitis C virus NS58 polymerase inhibitors. J Chem Inf Model 2008, 48:42-55.
14. Sheng C, Zhang W, Ji H, Zhang M, Song Y, Xu H, Zhu J, Miao Z, Jiang Q, Yao J, et al. Structure-based optimization of azole antifungal agents by CoMFA, CoMSIA, and molecular docking. J Med Chem 2006, 49:2512-2525.
15. Guido RVC, Oliva G, Montanari CA, Andricopulo AD. Structural basis for selective inhibition of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase: molecular docking and 3D QSAR studies. J Chem Inf Model 2008, 48:918-929.
16. Cozzini P, Kellogg GE, Spyrakis F, Abraham DJ, Costantino G, Emerson A, Fanelli F, Gohlke H, Kuhn LA, Morris GM. Target flexibility: an emerging consideration in drug discovery and design. J Med Chem 2008, 51:6237-6255.
17. Clark RD. A ligand's-eye view of protein binding. J Comput Aided Mol Des 2008, 22:507-521.
18. Jain AN. Surflex-Dock 2.1: robust performance from ligand energetic modeling, ring flexibility, and knowledge-based search. J Comput Aided Mol Des 2007, 21:281-306.
19. Wolohan P, Reichert DE. CoMFA and docking study of novel estrogen receptor subtype selective ligands. J Comput Aided Mol Des 2003, 17:313-328.
20. Huang N, Shoichet BK, Irwin JJ. Benchmarking sets for molecular docking. J Med Chem 2006, 49:6789-6801.
21. Ortiz AR, Pisabarro MT, Gago F, Wade RC. Prediction of drug binding affinities by comparative binding energy analysis. J Med Chem 1995, 38:2681-2691.
22. Enyedy IJ, Egan WJ. Can we use docking and scoring for hit-to-lead optimization? J Comput Aided Mol Des 2008, 22:161-168.
23. Lushington GH, Guo J-X, Wang JL. Whither combine? New opportunities for receptor-based QSAR. Curr Med Chem 2007, 14:1863-1877.